Abstract
Life Science Analytics' , "Genetic Diseases and Dysmorphic Syndromes Turner' s
Syndrome " contains detailed information on the current drug pipeline. This
report provides insight into the pipeline status of allergy drugs by company
and by stage as well as a summary of the latest news and developments in this
area.
Scope of the report:
Each Life Science Analytics' Therapy Area Pipeline Report provides the user
with real detail on drug pipelines, by company and by stage, for each specific
therapy area. The latest news, by company, also ensures that each report is
fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each
report also contains extensive information in tabular format on a company' s
full product pipeline and products by phase of development with regard to the
therapy area.
Full pipeline details, by stage, are provided and include detailed product
descriptions, information on partnering activity plus clinical trial
intelligence. Each Therapy Area Pipeline Report also provides detail on the
top 20 companies with products in the early stage of development and the top
20 companies with products in the late stage of development. Finally, each
report also provides a comparison with other major indications in the disease
hub based on Marketed Products vs. Pipeline Products.
Key benefits
・ Understand a company' s strategic position by accessing detailed independent
intelligence on its product pipeline for specific therapy areas.
・ Keep
track of your competitors and partners by better understanding their product
pipeline.
・ Monitor a company' s research effectiveness by determining
pipeline depth and number of products in development by clinical phase for
specific disease areas.
・ Maintain a critical competitive advantage.
| 
View Cart
